NCT01888341View on ClinicalTrials.gov

Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Healthy
Interventions
DRUG

Isotretinoin

Isotretinoin Capsules,20 mg

Trial Locations (1)

27514

AAI, Quadrangle Drive, Chapel Hill,

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY